Cefazolin Sodium is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by B. Braun Medical Inc.. The primary component is Cefazolin Sodium.
| Product ID | 0264-3105_07ff4148-ce54-490b-9aaf-a6e3d2be3028 |
| NDC | 0264-3105 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Cefazolin Sodium |
| Generic Name | Cefazolin Sodium |
| Dosage Form | Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2012-01-13 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050779 |
| Labeler Name | B. Braun Medical Inc. |
| Substance Name | CEFAZOLIN SODIUM |
| Active Ingredient Strength | 2 g/50mL |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2012-01-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050779 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2012-01-13 |
| Ingredient | Strength |
|---|---|
| CEFAZOLIN SODIUM | 2 g/50mL |
| SPL SET ID: | 17f8f038-c204-4dab-80d7-6f7ac41ddbec |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0264-3103 | Cefazolin Sodium | Cefazolin Sodium |
| 0264-3105 | Cefazolin Sodium | Cefazolin Sodium |
| 52533-014 | Cefazolin Sodium | Cefazolin Sodium |
| 52533-113 | Cefazolin Sodium | Cefazolin Sodium |
| 52533-120 | Cefazolin Sodium | Cefazolin Sodium |
| 0338-3503 | Cefazolin | Cefazolin Sodium |
| 0338-3508 | Cefazolin | Cefazolin Sodium |
| 25021-100 | Cefazolin | Cefazolin Sodium |
| 25021-101 | Cefazolin | Cefazolin Sodium |
| 25021-102 | Cefazolin | cefazolin sodium |
| 52584-023 | Cefazolin | Cefazolin Sodium |
| 55154-9559 | CEFAZOLIN | CEFAZOLIN SODIUM |
| 63323-236 | CEFAZOLIN | CEFAZOLIN SODIUM |